HER-2 V773L
|
HER2 Negative Breast Cancer
|
HER-2 V773L
|
HER2 Negative Breast Cancer
|
neratinib Sensitive: D – Preclinical
|
neratinib Sensitive: D – Preclinical
|
HER-2 V773L
|
HER2 Positive Breast Cancer
|
HER-2 V773L
|
HER2 Positive Breast Cancer
|
trastuzumab Sensitive: D – Preclinical
|
trastuzumab Sensitive: D – Preclinical
|